The impact of a nutritional intervention based on egg white for phosphorus control in hemodialyis patients

Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):45-50. doi: 10.1016/j.numecd.2018.09.010. Epub 2018 Sep 28.

Abstract

Background and aims: Here we describe a dietary intervention for hyperphosphatemia in dialysis patients based on the partial replacement of meat and fish, which are one of the main sources of alimentary phosphorous, with egg white, a virtually phosphorous-free protein source. This intervention aims to reduce phosphorous intake without causing protein wasting.

Patients and methods: As many as 23 hyperphosphatemic patients (15 male and 8 female, mean age 53.0 ± 10.0 years) on chronic standard 4 h, three times weekly, bicarbonate hemodialysis were enrolled in this open-label, randomized controlled trial. Patients in the intervention group were instructed to replace fish or meat with egg white in three meals a week for three months whereas diet was unchanged in the control group.

Results: Serum phosphate concentrations were significantly lower in the intervention group than in controls after three (4.9 ± 1.0 vs 6.6 ± 0.8; p < 0.001) but not after one month of treatment. Phosphate concentrations decreased more from baseline in the intervention than in the control group both after one (-1,2 ± 1,1 vs 0,5 ± 1,1; p = 0.004) and after three (-1,7 ± 1,1 vs -0,6 ± 1,1; p < 0.001) months of follow-up. No change either in body weight or in body composition assessed with bioelectrical impedance analysis or in serum albumin concentration was observed in either group.

Conclusion: The partial replacement of meat and fish with egg white induces a significant decrease in serum phosphate without causing protein malnutrition and could represent a useful instrument to control serum phosphate levels in hemodialysis patients. CLINICALTRIALS.

Gov identifier: NCT03236701.

Keywords: Dietary treatment; Egg white; Hemodialysis; Hyperphosphatemia; Protein energy wasting.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Body Composition
  • Egg Proteins, Dietary / administration & dosage*
  • Egg Proteins, Dietary / adverse effects
  • Female
  • Humans
  • Hyperphosphatemia / blood
  • Hyperphosphatemia / diagnosis
  • Hyperphosphatemia / diet therapy*
  • Hyperphosphatemia / etiology
  • Italy
  • Male
  • Meat / adverse effects*
  • Middle Aged
  • Phosphorus, Dietary / adverse effects*
  • Phosphorus, Dietary / blood
  • Protein-Energy Malnutrition / etiology
  • Protein-Energy Malnutrition / prevention & control
  • Renal Dialysis* / adverse effects
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / therapy*
  • Seafood / adverse effects*
  • Time Factors
  • Treatment Outcome

Substances

  • Egg Proteins, Dietary
  • Phosphorus, Dietary

Associated data

  • ClinicalTrials.gov/NCT03236701